-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
After the results of the centralized procurement of Chinese patent medicines in 19 provinces in Hubei were released, the provinces of the alliance began to implement them continuously
.
.
Hunan requires smooth admission channels, and the purchase amount of all drugs in the centralized procurement catalog (including selected drugs and non-selected drugs listed on the Internet) shall not exceed 85% of the same period of the previous year
.
This control method indicates that the volume and price of this variety will fall
.
.
This control method indicates that the volume and price of this variety will fall
.
If the average daily treatment cost of non-selected drugs in the same product group is lower than the minimum average daily treatment cost of selected drugs in the same product group, they can be included in the selected list upon application
.
The non-selected varieties are subject to price-limited listings
.
.
The non-selected varieties are subject to price-limited listings
.
On August 30, the Hunan Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of Centralized Procurement of Proprietary Medicines in Inter-Provincial Alliances", clarifying that the results of the centralized procurement of Chinese patent medicines alliances will be in the province's unified medical insurance on October 20, 2022.
The information platform "Medicine and Medical Consumables Recruitment and Procurement Management Subsystem" is implemented
.
At the same time, all drugs of the same product group will stop being purchased on the original provincial centralized pharmaceutical procurement platform
.
The procurement cycle is in principle 2 years
.
The information platform "Medicine and Medical Consumables Recruitment and Procurement Management Subsystem" is implemented
.
At the same time, all drugs of the same product group will stop being purchased on the original provincial centralized pharmaceutical procurement platform
.
The procurement cycle is in principle 2 years
.
It is worth noting that the "Notice" requires that the amount other than the purchase amount be clearly stipulated.
According to clinical needs, medical institutions can purchase unselected drugs at a suitable price, and all drugs in the centralized procurement catalog of Chinese patent medicines (including selected drugs and non-selected drugs listed on the Internet).
) The purchase amount shall not exceed 85% of the same period of the previous year
.
According to clinical needs, medical institutions can purchase unselected drugs at a suitable price, and all drugs in the centralized procurement catalog of Chinese patent medicines (including selected drugs and non-selected drugs listed on the Internet).
) The purchase amount shall not exceed 85% of the same period of the previous year
.
This control method has never been seen before, which indicates that the volume and price of the field will fall.
If you want to obtain the so-called "increment", you can only play the stock game in the limited or even shrinking "cake": you take more A bigger size means that others take less, and while the overall plate is shrinking, the competition is also more intense
.
If you want to obtain the so-called "increment", you can only play the stock game in the limited or even shrinking "cake": you take more A bigger size means that others take less, and while the overall plate is shrinking, the competition is also more intense
.
Under this limit, it is expected that various medical institutions should tilt towards the selected varieties in the selection of varieties, especially those selected at low prices to ensure that the amount of medication does not exceed the standard
.
.
The "Notice" requires medical institutions to unblock the channels for selected drugs to enter the hospital, conduct purchase transactions through the medical insurance recruitment and procurement system, and not to purchase drugs from outside the Internet or from non-specified channels; and not to conduct price increases in disguised forms such as off-line bargaining and any form of price discounts.
into behavior
.
into behavior
.
For non-selected varieties, the "Notice" clarifies that if the average daily treatment cost of non-selected drugs in the same product group is lower than the minimum average daily treatment cost of selected drugs in the same product group, they can be included in the selected list upon application
.
.
For non-selected drugs, the highest price limit for the entire group is set based on the highest value of the price of the selected drug with the largest drop in the same product group and the current highest online price in our province, and the price limit is implemented
.
.
The non-selected drugs that have been listed on the Internet will be included in the "Monitoring Catalogue of Chinese Patent Medicines" in conjunction with the lowest effective online price in the country, the lowest effective transaction price and not higher than the highest online limit price;
For non-selected drugs that have not been listed on the Internet, the manufacturer may, in accordance with the "Notice on Standardizing the Procurement of Drugs on the Internet" (Xiangyibaofa [2021] No.
2), link the lowest effective online price and the lowest effective transaction price in the country without any The price higher than the maximum online limit is included in the "Monitoring Catalogue of Chinese Patent Medicines"
.
Drugs for which the medical insurance payment standard has been piloted shall be settled according to the adjusted medical insurance payment standard .
2), link the lowest effective online price and the lowest effective transaction price in the country without any The price higher than the maximum online limit is included in the "Monitoring Catalogue of Chinese Patent Medicines"
.
Drugs for which the medical insurance payment standard has been piloted shall be settled according to the adjusted medical insurance payment standard .
In terms of payment settlement, direct settlement of payment for goods will be implemented on a trial basis, and the payment for selected medicines will be directly settled by the medical insurance fund
.
Before the trial of direct settlement of medical insurance funds, the payment for medicines will be temporarily settled offline by medical institutions and related pharmaceutical companies .
In principle, the payment for selected products should not be settled more than the end of the month after the delivery acceptance
.
.
Before the trial of direct settlement of medical insurance funds, the payment for medicines will be temporarily settled offline by medical institutions and related pharmaceutical companies .
In principle, the payment for selected products should not be settled more than the end of the month after the delivery acceptance
.
In terms of distribution, it is clarified that the selected enterprises will independently select enterprises with strong distribution capabilities and good reputation to distribute the selected drugs.
In principle, there are no less than 3 enterprises in each city-level overall planning area .
In accordance with the purchase and sale agreement, a production enterprise emergency reserve, inventory and production capacity reporting system shall be established
.
In principle, there are no less than 3 enterprises in each city-level overall planning area .
In accordance with the purchase and sale agreement, a production enterprise emergency reserve, inventory and production capacity reporting system shall be established
.
In terms of supervision, for medical institutions with serious delays in work progress and obvious abnormality in purchase quantity and purchase amount, measures such as interviews, letter inquiries, suspension of refusal to pay medical insurance settlement funds, and corresponding deduction of annual medical insurance reservations will be taken as appropriate to punish medical institutions.
.
.
Compensation, punishment, withdrawal, alternative and emergency safeguard measures shall be taken for acts that cannot guarantee the quality and quantity during execution to ensure the safety of patients
.
Records of pharmaceutical companies that fail to perform well in the contract shall be substantively included in the evaluation of the company's supply capacity and contract performance, and shall be dealt with according to the discretionary benchmarks of drug prices and credit evaluation of recruitment and procurement, depending on the severity of the circumstances
.
The time points are as follows:
.
Records of pharmaceutical companies that fail to perform well in the contract shall be substantively included in the evaluation of the company's supply capacity and contract performance, and shall be dealt with according to the discretionary benchmarks of drug prices and credit evaluation of recruitment and procurement, depending on the severity of the circumstances
.
The time points are as follows:
Before September 20, 2022, a distribution relationship covering the whole province will be established
.
.
On September 30, 2022, the medical institution determined the purchase volume agreed in the agreement
.
.
Before October 20, 2022, in principle, the signing of the three-party purchase and sales agreement with volume will be completed.
If the agreement is seriously overdue due to the failure of timely maintenance of the distribution relationship or the failure of the company to respond in time, the purchase and sales agreement will be cancelled and the agreed purchase volume will be Deduct accordingly
.
If the agreement is seriously overdue due to the failure of timely maintenance of the distribution relationship or the failure of the company to respond in time, the purchase and sales agreement will be cancelled and the agreed purchase volume will be Deduct accordingly
.
After the results of the centralized procurement of Chinese patent medicines in 19 provinces in Hubei were released, the provinces of the alliance began to implement them continuously
.
.
Hunan requires smooth admission channels, and the purchase amount of all drugs in the centralized procurement catalog (including selected drugs and non-selected drugs listed on the Internet) shall not exceed 85% of the same period of the previous year
.
This control method indicates that the volume and price of this variety will fall
.
.
This control method indicates that the volume and price of this variety will fall
.
If the average daily treatment cost of non-selected drugs in the same product group is lower than the minimum average daily treatment cost of selected drugs in the same product group, they can be included in the selected list upon application
.
The non-selected varieties are subject to price-limited listings
.
.
The non-selected varieties are subject to price-limited listings
.
On August 30, the Hunan Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of Centralized Procurement of Proprietary Medicines in Inter-Provincial Alliances", clarifying that the results of the centralized procurement of Chinese patent medicines alliances will be in the province's unified medical insurance on October 20, 2022.
The information platform "Medicine and Medical Consumables Recruitment and Procurement Management Subsystem" is implemented
.
At the same time, all drugs of the same product group will stop being purchased on the original provincial centralized pharmaceutical procurement platform
.
The procurement cycle is in principle 2 years
.
The information platform "Medicine and Medical Consumables Recruitment and Procurement Management Subsystem" is implemented
.
At the same time, all drugs of the same product group will stop being purchased on the original provincial centralized pharmaceutical procurement platform
.
The procurement cycle is in principle 2 years
.
It is worth noting that the "Notice" requires that the amount other than the purchase amount be clearly stipulated.
According to clinical needs, medical institutions can purchase unselected drugs at a suitable price, and all drugs in the centralized procurement catalog of Chinese patent medicines (including selected drugs and non-selected drugs listed on the Internet).
) The purchase amount shall not exceed 85% of the same period of the previous year
.
According to clinical needs, medical institutions can purchase unselected drugs at a suitable price, and all drugs in the centralized procurement catalog of Chinese patent medicines (including selected drugs and non-selected drugs listed on the Internet).
) The purchase amount shall not exceed 85% of the same period of the previous year
.
This control method has never been seen before, which indicates that the volume and price of the field will fall.
If you want to obtain the so-called "increment", you can only play the stock game in the limited or even shrinking "cake": you take more A bigger size means that others take less, and while the overall plate is shrinking, the competition is also more intense
.
If you want to obtain the so-called "increment", you can only play the stock game in the limited or even shrinking "cake": you take more A bigger size means that others take less, and while the overall plate is shrinking, the competition is also more intense
.
Under this limit, it is expected that various medical institutions should tilt towards the selected varieties in the selection of varieties, especially those selected at low prices to ensure that the amount of medication does not exceed the standard
.
.
The "Notice" requires medical institutions to unblock the channels for selected drugs to enter the hospital, conduct purchase transactions through the medical insurance recruitment and procurement system, and not to purchase drugs from outside the Internet or from non-specified channels; and not to conduct price increases in disguised forms such as off-line bargaining and any form of price discounts.
into behavior
.
into behavior
.
For non-selected varieties, the "Notice" clarifies that if the average daily treatment cost of non-selected drugs in the same product group is lower than the minimum average daily treatment cost of selected drugs in the same product group, they can be included in the selected list upon application
.
.
For non-selected drugs, the highest price limit for the entire group is set based on the highest value of the price of the selected drug with the largest drop in the same product group and the current highest online price in our province, and the price limit is implemented
.
.
The non-selected drugs that have been listed on the Internet will be included in the "Monitoring Catalogue of Chinese Patent Medicines" in conjunction with the lowest effective online price in the country, the lowest effective transaction price and not higher than the highest online limit price;
For non-selected drugs that have not been listed on the Internet, the manufacturer may, in accordance with the "Notice on Standardizing the Procurement of Drugs on the Internet" (Xiangyibaofa [2021] No.
2), link the lowest effective online price and the lowest effective transaction price in the country without any The price higher than the maximum online limit is included in the "Monitoring Catalogue of Chinese Patent Medicines"
.
Drugs for which the medical insurance payment standard has been piloted shall be settled according to the adjusted medical insurance payment standard .
standard standard medicines _2), link the lowest effective online price and the lowest effective transaction price in the country without any The price higher than the maximum online limit is included in the "Monitoring Catalogue of Chinese Patent Medicines"
.
Drugs for which the medical insurance payment standard has been piloted shall be settled according to the adjusted medical insurance payment standard .
In terms of payment settlement, direct settlement of payment for goods will be implemented on a trial basis, and the payment for selected medicines will be directly settled by the medical insurance fund
.
Before the trial of direct settlement of medical insurance funds, the payment for medicines will be temporarily settled offline by medical institutions and related pharmaceutical companies .
In principle, the payment for selected products should not be settled more than the end of the month after the delivery acceptance
.
Pharmaceutical and pharmaceutical enterprises.
Before the trial of direct settlement of medical insurance funds, the payment for medicines will be temporarily settled offline by medical institutions and related pharmaceutical companies .
In principle, the payment for selected products should not be settled more than the end of the month after the delivery acceptance
.
In terms of distribution, it is clarified that the selected enterprises will independently select enterprises with strong distribution capabilities and good reputation to distribute the selected drugs.
In principle, there are no less than 3 enterprises in each city-level overall planning area .
In accordance with the purchase and sale agreement, a production enterprise emergency reserve, inventory and production capacity reporting system shall be established
.
purchase purchaseIn principle, there are no less than 3 enterprises in each city-level overall planning area .
In accordance with the purchase and sale agreement, a production enterprise emergency reserve, inventory and production capacity reporting system shall be established
.
In terms of supervision, for medical institutions with serious delays in work progress and obvious abnormality in purchase quantity and purchase amount, measures such as interviews, letter inquiries, suspension of refusal to pay medical insurance settlement funds, and corresponding deduction of annual medical insurance reservations will be taken as appropriate to punish medical institutions.
.
.
Compensation, punishment, withdrawal, alternative and emergency safeguard measures shall be taken for acts that cannot guarantee the quality and quantity during execution to ensure the safety of patients
.
Records of pharmaceutical companies that fail to perform well in the contract shall be substantively included in the evaluation of the company's supply capacity and contract performance, and shall be dealt with according to the discretionary benchmarks of drug prices and credit evaluation of recruitment and procurement, depending on the severity of the circumstances
.
The time points are as follows:
.
Records of pharmaceutical companies that fail to perform well in the contract shall be substantively included in the evaluation of the company's supply capacity and contract performance, and shall be dealt with according to the discretionary benchmarks of drug prices and credit evaluation of recruitment and procurement, depending on the severity of the circumstances
.
The time points are as follows:
Before September 20, 2022, a distribution relationship covering the whole province will be established
.
.
On September 30, 2022, the medical institution determined the purchase volume agreed in the agreement
.
.
Before October 20, 2022, in principle, the signing of the three-party purchase and sales agreement with volume will be completed.
If the agreement is seriously overdue due to the failure of timely maintenance of the distribution relationship or the failure of the company to respond in time, the purchase and sales agreement will be cancelled and the agreed purchase volume will be Deduct accordingly
.
If the agreement is seriously overdue due to the failure of timely maintenance of the distribution relationship or the failure of the company to respond in time, the purchase and sales agreement will be cancelled and the agreed purchase volume will be Deduct accordingly
.
